DGAP-News: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development
|
Issuer: CureVac
/ Key word(s): Alliance
CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development 25.05.2022 / 13:00 The issuer is solely responsible for the content of this announcement. |